Neervannan Seshadri's Form 4 filing
Tarsus Pharmaceuticals, Inc. (TARS) · filed Mar 19, 2024
- Accession no.
- 0001819790-24-000043
- Filed
- Mar 19, 2024
- Trade date
- Mar 15-18, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $149.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Neervannan SeshadriCIK 0001827584 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Common Stock | MOption exerciseAcquired | +13,245 | –F1 | – | 69,646 | Direct | |
| Mar 18, 2024 | Common Stock | SSaleDisposed | −4,879 | $30.60 | −$149,297.4 | 64,767 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Common Stock | MOption exerciseDisposed | −5,097 | $0.00 | $0 | 10,194 | Direct | |
| Mar 15, 2024 | Common Stock | MOption exerciseDisposed | −8,148 | $0.00 | $0 | 24,444 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit 24 - Power of Attorney